E. Richard Stanley
- Immunology top 0.5%
- Immune Response and Inflammation 9
- Immune cells in cancer 6
- Immunotherapy and Immune Responses 5
- Hematology top 2%
- Oncology top 2%
- Immunology and Allergy top 2%
- Cell Adhesion Molecules Research 5
- Neurology top 5%
-
- Virus-based gene therapy research 5
-
- Monoclonal and Polyclonal Antibodies Research 5
-
- Bone Metabolism and Diseases 4
- Glycosylation and Glycoproteins Research 4
- Co-authors
- Violeta ChiţuA. BartocciL.J. GuilbertJeffrey W. PollardD MetcalfSH BartelmezYee-Guide YeungSudip Das
- Cited by
- ImmunologyHematologyOncology
- Partner nations
- United StatesFranceAustralia
In The Last Decade
E. Richard Stanley
52 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Immunology 2.6k
- Hematology 590
- Oncology 1.0k
- Immunology and Allergy 231
- Neurology 262
Countries citing papers authored by E. Richard Stanley
This map shows the geographic impact of E. Richard Stanley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Richard Stanley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Richard Stanley more than expected).
Fields of papers citing papers by E. Richard Stanley
This network shows the impact of papers produced by E. Richard Stanley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Richard Stanley. The network helps show where E. Richard Stanley may publish in the future.
Co-authorship network
The 25 scholars most cited alongside E. Richard Stanley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 24 | |
| 2 | CSF-1 Receptor Signaling in Myeloid Cellsbreakdown → | 2014 | 584 |
| 3 | 2011 | 122 | |
| 4 | 2010 | 76 | |
| 5 | 2009 | 96 | |
| 6 | 2009 | 84 | |
| 7 | 2008 | 83 | |
| 8 | 2004 | 115 | |
| 9 | 2003 | 89 | |
| 10 | 2001 | 4 | |
| 11 | 1997 | 43 | |
| 12 | 1995 | 71 | |
| 13 | 1993 | 148 | |
| 14 | 1993 | 42 | |
| 15 | Correction by CSF-1 of defects in the osteopetrotic op/op mouse suggests local, developmental, and humoral requirements for this growth factor. | 1991 | 161 |
| 16 | Apparent role of the macrophage growth factor, CSF-1, in placental developmentbreakdown → | 1987 | 426 |
| 17 | 1987 | 35 | |
| 18 | 1986 | 265 | |
| 19 | 1986 | 26 | |
| 20 | 1984 | 310 |
About E. Richard Stanley
E. Richard Stanley is a scholar working on Immunology, Immunology and Allergy and Hematology, having authored 52 papers that have together received 5.0k indexed citations. Recurring topics across this work include Immune Response and Inflammation (9 papers), Immune cells in cancer (6 papers), Virus-based gene therapy research (5 papers), Immunotherapy and Immune Responses (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Cell Adhesion Molecules Research (5 papers), Bone Metabolism and Diseases (4 papers) and Glycosylation and Glycoproteins Research (4 papers). The work is most often cited by research in Immunology (2.6k citations), Hematology (590 citations) and Oncology (1.0k citations). E. Richard Stanley has collaborated with scholars based in United States, France and Australia. Frequent co-authors include Violeta Chiţu, A. Bartocci, L.J. Guilbert, Jeffrey W. Pollard, D Metcalf, SH Bartelmez, Yee-Guide Yeung, Sudip Das, Martha Ladner and R.J. Arceci. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.